Neuronal and astroglial monoamine oxidase: pharmacological implications of specific MAO-B inhibitors

Prog Brain Res. 1992:94:309-15. doi: 10.1016/s0079-6123(08)61760-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Astrocytes / drug effects*
  • Astrocytes / enzymology
  • Dopamine / metabolism*
  • Models, Neurological
  • Monoamine Oxidase / physiology*
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Nerve Degeneration
  • Nerve Tissue Proteins / antagonists & inhibitors*
  • Nerve Tissue Proteins / physiology
  • Neurons / drug effects*
  • Neurons / enzymology
  • Oxidation-Reduction
  • Phenethylamines / pharmacology
  • Rats
  • Selegiline / pharmacology
  • Structure-Activity Relationship

Substances

  • Monoamine Oxidase Inhibitors
  • Nerve Tissue Proteins
  • Phenethylamines
  • Selegiline
  • phenethylamine
  • Monoamine Oxidase
  • Dopamine